---
title: 'Associate Process Engineer (12 month contract) at Aspect Biosystems'
canonical: 'https://feeny.ai/job/associate-process-engineer-12-month-contract-aspect-biosystems-vancouver-vqs5c9teynn2'
type: 'job'
last_seen: '2026-09-04'
---

# Associate Process Engineer (12 month contract) at Aspect Biosystems

- **Company:** Aspect Biosystems
- **Location:** Vancouver, Canada
- **Work type:** onsite
- **Posted:** 2026-08-21
- **Last confirmed live:** 2026-09-04
- **Apply:** https://job-boards.greenhouse.io/aspectbiosystems/jobs/5398727008

## Job description

We're looking for an enthusiastic Associate Process Engineer to join our dynamic and dedicated Process Development team. Reporting to the Head of Process Development, you will support the development of an aseptic manufacturing workflow for our bioprinted tissue therapeutics. You’ll be joining a company committed to developing regenerative medicines that deliver life-changing, functional cures for patients living with serious diseases. .

## Responsibilities

- Assisting in the design, execution, and characterization of fluidic systems, bioreactor scaling strategies, and automated cell processing workflows (wash, concentrate, harvest) to support process robustness.
- Collaborating with Process Development, Bioengineering, Engineering, and Manufacturing team members to support technical integration of the cell therapy process into the final device platform, focusing on closed-system design and single-use technologies.
- Participating in process risk assessments (e.g., FMEA, PHA) for both the cell manufacturing process and its interaction with the medical device component.
- Utilizing mathematical models and Design of Experiments (DOE) methodologies under senior guidance to assist in defining critical process parameters (CPPs) and critical quality attributes (CQAs).
- Supporting technology transfer to Manufacturing, including assisting with process qualification and early phase clinical manufacturing as needed.
- Contributing to technical troubleshooting and assisting with out-of-specification investigation and root cause analysis during manufacturing deviations or process improvements.
- Supporting the execution of validation strategies for sterilization, biocompatibility, and extractables/leachables (E&L), and helping compile technical data for regulatory filings (CTA/IND).
- Identifying process improvement opportunities in current cell therapy manufacturing to help optimize yield, purity, and scalability.
- Continuously building your technical expertise while contributing to a culture of rigor and data-driven decision-making.

## Qualifications

- Education + Experience: M.S. or BSc. in Chemical Engineering, Bioengineering, Biomedical Engineering, or a related life science field with 1-2+ years of relevant industry experience, in cell therapy, bioprocess development, or biologics manufacturing.
- Process Development & Characterization Experience: Hands-on background in the development, characterization, and optimization of biomanufacturing processes is required, preferably within cell therapy.
- Bioreactors: Experience with bioreactor systems and scaling strategies is desirable.
- GMP & GDP Knowledge: Knowledge of Good Manufacturing Practices (GMP) and Good Documentation Practices (GDP). Familiarity with regulatory requirements for cell therapy products (e.g., providing technical content for CTA/IND filings).
- Analytical and Communication Skills: Analytical, problem-solving, and data-driven decision-making skills. Excellent written and verbal communication skills, including the ability to present complex data and mentor junior team members.

The hiring range for this role is $64,000 - $72,000 CAD annually. Our ranges are based on market data. Offered salaries will be based on a combination of factors including, but not limited to, job-related knowledge, skills, education, and experience. For candidates who exceed role requirements, we are open to exploring above-range offers. Note that base salary is just one part of the overall compensation at Aspect. Members of the Aspect team also receive a comprehensive benefits package, and support for continuous learning and career progression.

## Who We Are

Aspect Biosystems is a biotechnology company pioneering the development of a novel category of regenerative medicine designed to restore or supplement biological function and deliver curative therapies for some of the most elusive diseases. Aspect is developing these bioengineered cellular medicines by applying its full-stack tissue therapeutic platform, which integrates proprietary AI-powered bioprinting technology, therapeutic cells, hypoimmune cell engineering, and advanced biomaterials. Aspect is advancing its therapeutic pipeline across multiple endocrine and metabolic diseases, including diabetes and rare endocrine disorders. If you are committed to making a real impact and accelerating the development of life-changing therapies, we want to hear from you!

Curious about our current perks and benefits? Learn more [here](https://aspectbiosystems.com/careers).

At Aspect Biosystems, our strength has always been in our diversity. Different people, thinking differently, unified in creating a world that is better for us all. We are committed to creating an inclusive environment for everyone on our team.

All aspects of employment — including the decision to hire, promote, discipline, or terminate — are based on merit, competence, performance, and business needs. We do not discriminate on the basis of race, color, religion, citizenship status, marital status, age, national origin, ancestry, physical or mental disability, medical condition, pregnancy, genetic information, gender, sexual orientation, gender identity or expression, veteran status, political affiliation, or any other status protected under federal, state, provincial, or local law.

If you're interested in joining our team but don't see a job posting that matches your experience or background, we encourage you to [submit a general application](https://boards.greenhouse.io/aspectbiosystems/jobs/4009049008) to be considered for future opportunities!

## About Aspect Biosystems

## Company Overview
- **One-liner**: Aspect Biosystems is a Canadian biotechnology company pioneering the development of Bioprinted Tissue Therapeutics—implantable, bioengineered cellular medicines designed to replace, repair, or supplement biological function to treat incurable diseases.
- **Entity Type**: Private (Series Unknown; raised US$350M+ in total capital)
- **Headquarters**: Vancouver, British Columbia, Canada
- **Founded**: 2013
- **Founders**: Tamer Mohamed (CEO), Simon Beyer (CTO), Sam Wadsworth (CSO)

## Core Business
- **Primary Industry**: Biotechnology / Regenerative Medicine / Tissue Engineering
- **Target Customers**: B2B (pharmaceutical and biotech partners for co-development and clinical trials), and ultimately B2B2C (patients with metabolic and endocrine diseases such as diabetes).
- **Mission**: To develop Bioprinted Tissue Therapeutics that replace, repair, or supplement biological function, transforming the treatment of incurable diseases.

## Products & Services
- **Bioprinted Tissue Therapeutics (Pipeline)**: Implantable, allogeneic tissues designed to treat metabolic and endocrine diseases (e.g., diabetes, rare endocrine disorders). These are bioengineered cellular medicines that integrate proprietary AI-powered bioprinting, therapeutic cells, hypoimmune cell engineering, and advanced biomaterials.
- **Full-Stack Tissue Therapeutic Platform**: A vertically integrated technology stack that includes AI-powered bioprinting systems, microfluidic printheads, lab automation, software, machine learning, and computational design tools. This platform is used for internal pipeline development and partnered programs.
- **Partnerships (Co-Development)**: Collaborates with pharmaceutical and biotech leaders (e.g., Novo Nordisk) to bring cutting-edge cell therapies to the clinic, leveraging its platform for co-development.

## Market Standing
- **Valuation/Market Cap**: Not publicly disclosed.
- **Key Metric**: Total funding raised is over US$350M (including a US$280M partnership with the Government of Canada announced in 2026, a US$115M round in 2024, and a US$72.75M government investment in 2024). LinkedIn reports total funding at US$278.7M.
- **Notable Investors/Partners**: Novo Nordisk (major pharma partner), Government of Canada (major strategic partner), Western Innovation (WINN) Initiative, entrepreneurship@UBC.
- **Growth Signals**: Headcount grew 26.5% YoY to 116 employees. Announced a new phase of partnership with Novo Nordisk in January 2026. Secured a US$280M partnership with the Government of Canada in April 2026. Won multiple awards including Life Sciences BC Company of the Year 2024 and BIOTECanada Biotech Company of the Year.

## Competitive Advantages
- **Full-Stack Platform**: Integrates proprietary AI-powered bioprinting, therapeutic cells, hypoimmune cell engineering, and advanced biomaterials—a vertically integrated approach that is difficult to replicate.
- **Strategic Partnerships**: Deep, multi-phase partnership with Novo Nordisk, a global leader in diabetes care, providing validation, funding, and clinical development expertise.
- **Government Support**: Significant non-dilutive funding and strategic backing from the Government of Canada (US$280M partnership), providing a strong financial runway and national-level support.
- **Experienced Leadership Team**: Leadership includes executives with deep experience from Vertex Pharmaceuticals, Novo Nordisk, BlueRock Therapeutics (Bayer), and ViaCyte (Vertex), bringing proven expertise in advancing cell therapies from research to late-stage clinical development.

## Strategic Focus
- **Clinical Translation**: Advancing its pipeline of Bioprinted Tissue Therapeutics toward first-in-human clinical trials, with a strong focus on diabetes and rare endocrine disorders.
- **Platform Expansion**: Continuing to develop and vertically integrate its full-stack tissue therapeutic platform (AI bioprinting, cell engineering, biomaterials) to enable a broad pipeline of therapies.
- **Strategic Partnerships**: Deepening its collaboration with Novo Nordisk to develop curative medicines for diabetes, and seeking additional pharma/biotech partners to leverage its platform for other indications.
- **Manufacturing & Scale-Up**: Building out technical operations, process development, and manufacturing capabilities to support clinical translation and eventual commercialization.

## Why Work Here
- **Mission-Driven Work**: Employees are directly contributing to developing transformative, curative therapies for incurable diseases, with a strong sense of purpose and impact.
- **Culture & Values**: Described as supportive, collaborative, and intellectually curious. The team is interdisciplinary (scientists, engineers, entrepreneurs) and globally diverse.
- **Compensation & Benefits**: Competitive salary, stock options, fully paid extended healthcare for employee and family, life insurance, AD&D, parental leave top-up, annual professional development allowance, health & wellness spending account.
- **Work-Life Balance**: Minimum 3 weeks' vacation plus a December holiday break, flexible work hours.
- **Work Environment**: On-site roles in Vancouver, BC. Office features collaboration spaces, board games, video games, employee-led groups (book club), nearby walking/cycling routes, underground bike cages, and on-site showers.
- **Culture**: Described as supportive, collaborative, intellectually curious, and mission-driven. Employees report feeling they make a meaningful impact. The team is interdisciplinary and globally diverse.
- **Recognition**: Named one of Canada's Best Employers for Recent Graduates, Life Sciences BC Company of the Year 2024, BIOTECanada Biotech Company of the Year, and Fast Company Next Big Things in Tech.

## Sources
1. [aspectbiosystems.com](https://www.aspectbiosystems.com/)
2. [aspectbiosystems.com/about](https://aspectbiosystems.com/about)
3. [aspectbiosystems.com/careers](https://aspectbiosystems.com/careers)
4. [job-boards.greenhouse.io/aspectbiosystems](http://job-boards.greenhouse.io/aspectbiosystems)
5. [linkedin.com/company/aspect-biosystems](https://ca.linkedin.com/company/aspect-biosystems)

## Other roles at Aspect Biosystems

- [Procurement Specialist](https://feeny.ai/job/procurement-specialist-aspect-biosystems-vancouver-9rpfgdhyvhnk) — Vancouver, Canada
- [Quality Assurance Specialist](https://feeny.ai/job/quality-assurance-specialist-aspect-biosystems-vancouver-7mta1vv2hgk0) — Vancouver, Canada
- [Senior Process Engineer (12 Month Contract)](https://feeny.ai/job/senior-process-engineer-12-month-contract-aspect-biosystems-vancouver-7w6pzvbsbr3p) — Vancouver, Canada
- [Associate, Process Development (Bioprinting)](https://feeny.ai/job/associate-process-development-bioprinting-aspect-biosystems-vancouver-x1vzyghndw6a) — Vancouver, Canada
- [Associate, Process Development (Cells)](https://feeny.ai/job/associate-process-development-cells-aspect-biosystems-vancouver-dnarb66fc5q4) — Vancouver, Canada
- [Scientist, Immunoengineering](https://feeny.ai/job/scientist-immunoengineering-aspect-biosystems-vancouver-txjd528gng86) — Vancouver, Canada
- [Scientist, Quality Control & Analytical Development](https://feeny.ai/job/scientist-quality-control-analytical-development-aspect-biosystems-fremont-9dpb6ccq0d4r) — Fremont
- [IT Systems Administrator](https://feeny.ai/job/it-systems-administrator-aspect-biosystems-vancouver-wfqq2313xq1g) — Vancouver, Canada
- [Head of Quality Assurance](https://feeny.ai/job/head-of-quality-assurance-aspect-biosystems-fremont-f3b8zjr40w1t) — Fremont
- [Project Manager](https://feeny.ai/job/project-manager-aspect-biosystems-vancouver-cttc6npvanbd) — Vancouver, Canada